Urology

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Lapatinib Helps Subset of Patients with Hepatocellular Carcinoma

Roberta Buell, MBA
Congress Proposes SGR Fix

Dorothy J. Schirf, MD

Technology Advances

Magnetic Nanosensor Prepped for Early Cancer Detection

Sara Hartley

Cancer Science

HPV Prevalence at Root of Racial Disparity in Head and Neck Cancer

See All Messages (38 new messages)

Your Article Summary

See Latest Articles

Ketamine-Associated Ulcerative Cystitis: A New Clinical Entity
Urology, 05/25/07

Rohan Shahani, M.D., et al. - Ketamine hydrochloride is an N-methyl-d-aspartic acid receptor antagonist used as an anesthetic agent in human and veterinary procedures. Increasingly, it is being used as a recreational drug. Recreational ketamine users have anecdotally reported increased lower urinary tract symptoms while using the substance...Conclusions: This case series has described a new clinical entity of severe ulcerative cystitis as a result of chronic ketamine use. As illicit ketamine becomes more easily available, ulcerative cystitis and potential long-term bladder sequelae related to its use may be a more prevalent problem confronting urologists

Today in Bladder...keeping you current

Receive free subspecialty "5-minute updates" via email

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09

Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09

Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09

See All of Bladder